| Apogee Therapeutics, Inc. | 11,447 | US$1.53M | 1.3% |
| Oruka Therapeutics, Inc. | 14,788 | US$1.43M | 1.2% |
| Dianthus Therapeutics, Inc. | 12,390 | US$1.32M | 1.1% |
| Erasca, Inc. | 70,819 | US$1.29M | 1.1% |
| Twist Bioscience Corporation | 13,972 | US$1.28M | 1.1% |
| Kymera Therapeutics, Inc. | 12,103 | US$1.25M | 1.1% |
| Spyre Therapeutics, Inc. | 12,611 | US$1.24M | 1.0% |
| Revolution Medicines, Inc. | 6,567 | US$1.23M | 1.0% |
| Cg Oncology, Inc. | 17,241 | US$1.23M | 1.0% |
| Protagonist Therapeutics, Inc. | 8,952 | US$1.22M | 1.0% |
| Praxis Precision Medicines, Inc. | 3,934 | US$1.21M | 1.0% |
| Regeneron Pharmaceuticals, Inc. | 1,574 | US$1.2M | 1.0% |
| Cogent Biosciences, Inc. | 30,174 | US$1.17M | 0.99% |
| Natera, Inc. | 4,373 | US$1.17M | 0.99% |
| Arrowhead Pharmaceuticals, Inc. | 13,387 | US$1.13M | 0.95% |
| Travere Therapeutics, Inc. | 20,258 | US$1.13M | 0.95% |
| Roivant Sciences Ltd. | 33,328 | US$1.13M | 0.95% |
| Relay Therapeutics, Inc. | 59,954 | US$1.13M | 0.95% |
| Moderna, Inc. | 20,588 | US$1.13M | 0.95% |
| Vaxcyte, Inc. | 20,847 | US$1.13M | 0.95% |
| Bridgebio Pharma, Inc. | 14,047 | US$1.13M | 0.95% |
| Halozyme Therapeutics, Inc. | 13,431 | US$1.11M | 0.93% |
| Rhythm Pharmaceuticals, Inc. | 11,047 | US$1.1M | 0.92% |
| Cytokinetics, Incorporated | 14,117 | US$1.09M | 0.92% |
| Viking Therapeutics, Inc. | 34,121 | US$1.08M | 0.91% |
| Amgen Inc. | 2,804 | US$1.08M | 0.91% |
| Incyte Corporation | 8,984 | US$1.07M | 0.90% |
| Mirum Pharmaceuticals, Inc. | 10,073 | US$1.07M | 0.90% |
| Alkermes Plc | 21,598 | US$1.06M | 0.89% |
| Tg Therapeutics, Inc. | 20,310 | US$1.06M | 0.89% |
| Abbvie Inc. | 4,209 | US$1.06M | 0.89% |
| Vertex Pharmaceuticals Incorporated | 2,173 | US$1.04M | 0.87% |
| Krystal Biotech, Inc. | 3,031 | US$1.03M | 0.87% |
| Insmed Incorporated | 10,305 | US$1.02M | 0.86% |
| Scholar Rock Holding Corporation | 21,476 | US$1.02M | 0.86% |
| Gilead Sciences, Inc. | 7,794 | US$1.01M | 0.86% |
| Biomarin Pharmaceutical Inc. | 16,857 | US$1.01M | 0.85% |
| Uniqure N.v. | 22,789 | US$994K | 0.84% |
| Dyne Therapeutics, Inc. | 39,481 | US$994K | 0.84% |
| Biogen Inc. | 4,875 | US$989K | 0.83% |
| Neurocrine Biosciences, Inc. | 5,886 | US$982K | 0.83% |
| Acadia Pharmaceuticals Inc. | 37,819 | US$978K | 0.82% |
| Exelixis, Inc. | 18,006 | US$955K | 0.80% |
| Immunovant, Inc. | 24,501 | US$946K | 0.80% |
| Madrigal Pharmaceuticals, Inc. | 2,009 | US$939K | 0.79% |
| Grail, Inc. | 13,555 | US$929K | 0.78% |
| Celcuity Inc. | 10,730 | US$927K | 0.78% |
| Summit Therapeutics Inc. | 70,875 | US$923K | 0.78% |
| Crispr Therapeutics Ag | 19,152 | US$919K | 0.77% |
| United Therapeutics Corporation | 1,740 | US$901K | 0.76% |
| Ptc Therapeutics, Inc. | 12,909 | US$878K | 0.74% |
| Ultragenyx Pharmaceutical Inc. | 34,869 | US$869K | 0.73% |
| Immunitybio, Inc. | 119K | US$852K | 0.72% |
| Sellas Life Sciences Group, Inc. | 82,286 | US$824K | 0.69% |
| Beam Therapeutics Inc. | 32,108 | US$819K | 0.69% |
| Biocryst Pharmaceuticals, Inc. | 90,976 | US$817K | 0.69% |
| Vera Therapeutics, Inc. | 25,201 | US$809K | 0.68% |
| Ideaya Biosciences, Inc. | 22,004 | US$781K | 0.66% |
| Denali Therapeutics Inc. | 33,047 | US$761K | 0.64% |
| Tango Therapeutics, Inc. | 27,490 | US$747K | 0.63% |
| Arcutis Biotherapeutics, Inc. | 27,707 | US$744K | 0.63% |
| Celldex Therapeutics, Inc. | 19,262 | US$733K | 0.62% |
| Viridian Therapeutics, Inc. | 37,302 | US$706K | 0.59% |
| Disc Medicine, Inc. | 9,122 | US$702K | 0.59% |
| Arcus Biosciences, Inc. | 24,602 | US$694K | 0.58% |
| Mineralys Therapeutics, Inc. | 26,819 | US$684K | 0.58% |
| Ionis Pharmaceuticals, Inc. | 12,914 | US$669K | 0.56% |
| Alnylam Pharmaceuticals, Inc. | 3,251 | US$668K | 0.56% |
| Veracyte, Inc. | 14,229 | US$659K | 0.56% |
| Immunome, Inc. | 28,528 | US$649K | 0.55% |
| Syndax Pharmaceuticals, Inc. | 33,542 | US$639K | 0.54% |
| Recursion Pharmaceuticals, Inc. | 210K | US$631K | 0.53% |
| Sarepta Therapeutics, Inc. | 42,415 | US$630K | 0.53% |
| Adma Biologics Inc | 74,090 | US$627K | 0.53% |
| Kodiak Sciences Inc | 14,257 | US$593K | 0.50% |
| Intellia Therapeutics, Inc. | 54,738 | US$585K | 0.49% |
| Agios Pharmaceuticals, Inc. | 19,065 | US$572K | 0.48% |
| Iovance Biotherapeutics, Inc. | 138K | US$562K | 0.47% |
| Nurix Therapeutics, Inc. | 23,449 | US$544K | 0.46% |
| Palvella Therapeutics, Inc. | 3,897 | US$542K | 0.46% |
| Novavax, Inc. | 71,547 | US$524K | 0.44% |
| Vericel Corporation | 11,387 | US$523K | 0.44% |
| Biohaven Ltd. | 36,145 | US$488K | 0.41% |
| Caredx, Inc. | 10,901 | US$476K | 0.40% |
| Stoke Therapeutics, Inc. | 15,004 | US$433K | 0.36% |
| Precigen, Inc. | 67,557 | US$424K | 0.36% |
| Tyra Biosciences, Inc. | 13,276 | US$423K | 0.36% |
| Vir Biotechnology, Inc. | 47,154 | US$408K | 0.34% |
| Zenas Biopharma, Inc. | 12,867 | US$405K | 0.34% |
| Anaptysbio, Inc. | 7,500 | US$400K | 0.34% |
| First Tracks Biotherapeutics, Inc. | 8,871 | US$391K | 0.33% |
| Absci Corporation | 49,479 | US$385K | 0.32% |
| Hyperliquid Strategies Inc | 60,350 | US$375K | 0.32% |
| Cullinan Therapeutics, Inc. | 22,670 | US$374K | 0.32% |
| Xencor, Inc. | 18,495 | US$374K | 0.31% |
| Corvus Pharmaceuticals, Inc. | 27,953 | US$371K | 0.31% |
| Vor Biopharma Inc. | 16,745 | US$354K | 0.30% |
| Avalo Therapeutics, Inc. | 19,350 | US$353K | 0.30% |
| Ardelyx, Inc. | 70,717 | US$350K | 0.29% |
| Oric Pharmaceuticals, Inc. | 31,133 | US$345K | 0.29% |